These peptides act as a biological mechanism behind skin regeneration and aging, and are therefore studied to ensure a safe human application in the future
Most common GLP-1 side effects The most common side effects of Semaglutide (GLP-1) medications include nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar) in patients with type 2 diabetes, flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder)
Studies have shown that individuals with AIDs have 40% to 100% increased risk of thromboembolic and cardiovascular complications
Some are FDA-approved for managing type 2 diabetes (even though they aid with weight loss), and some, such as the brand Zepbound by Eli Lilly, are now specifically approved for weight loss